Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 252
7
Diseases
15
Unique genes
0.304
Avg. similarity score
Dominant dystrophic epidermolysis bullosa with absence of skin
Most-connected disease (6 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Dominant dystrophic epidermolysis bullosa with absence of skin
Dominant dystrophic epidermolysis bullosa, albopapular type
recessive dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa
Hallopeau siemens disease
Nail dystrophy
Duane retraction syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Dominant dystrophic epidermolysis bullosa with absence of skin | 6 | 6 | 1 |
| Dominant dystrophic epidermolysis bullosa, albopapular type | 6 | 6 | 1 |
| recessive dystrophic epidermolysis bullosa | 6 | 6 | 1 |
| Dystrophic epidermolysis bullosa | 5 | 5 | 2 |
| Hallopeau siemens disease | 5 | 5 | 2 |
| Nail dystrophy | 5 | 5 | 2 |
| Duane retraction syndrome | 3 | 3 | 12 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| COL7A1 | 7 / 7 | Dominant dystrophic epidermolysis bullosa with absence of skin, Dominant dystrophic epidermolysis bullosa, albopapular type, Duane retraction syndrome, Dystrophic epidermolysis bullosa and 3 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Parkinson disease | KEGG | 4 / 268 | 12.0× | 2.73e-4 | 4.98e-3 ✓ sig. |
| Signaling by SCF-KIT | Reactome | 2 / 37 | 43.3× | 9.46e-4 | 1.30e-2 ✓ sig. |
| Motor proteins | KEGG | 3 / 194 | 12.4× | 1.64e-3 | 1.97e-2 ✓ sig. |
| Collagen degradation | Reactome | 2 / 52 | 30.8× | 1.86e-3 | 2.16e-2 ✓ sig. |
| Pathways of neurodegeneration - multiple diseases | KEGG | 4 / 480 | 6.7× | 2.42e-3 | 2.63e-2 ✓ sig. |
| Salmonella infection | KEGG | 3 / 248 | 9.7× | 3.29e-3 | 3.29e-2 ✓ sig. |
| Gap junction | KEGG | 2 / 89 | 18.0× | 5.36e-3 | 4.58e-2 ✓ sig. |
| Huntington disease | KEGG | 3 / 308 | 7.8× | 6.04e-3 | 4.96e-2 ✓ sig. |
| MET activates PTPN11 | Reactome | 1 / 5 | 160× | 6.23e-3 | 5.06e-2 |
| Parathyroid hormone synthesis, secretion and action | KEGG | 2 / 115 | 13.9× | 8.80e-3 | 6.35e-2 |
| Amyotrophic lateral sclerosis | KEGG | 3 / 368 | 6.5× | 9.87e-3 | 6.81e-2 |
| MHC class II antigen presentation | Reactome | 2 / 123 | 13.0× | 1.00e-2 | 6.85e-2 |
| Relaxin signaling pathway | KEGG | 2 / 130 | 12.3× | 1.11e-2 | 7.32e-2 |
| MAPK1 (ERK2) activation | Reactome | 1 / 9 | 89.0× | 1.12e-2 | 7.34e-2 |
| Dopaminergic synapse | KEGG | 2 / 132 | 12.1× | 1.15e-2 | 7.45e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| motor neuron axon guidance | GO:0008045 | 2 / 24 | 104× | 1.64e-4 | 4.39e-3 ✓ sig. |
| platelet-derived growth factor receptor signaling pathway | GO:0048008 | 2 / 33 | 75.5× | 3.13e-4 | 6.93e-3 ✓ sig. |
| ephrin receptor signaling pathway | GO:0048013 | 2 / 51 | 48.9× | 7.50e-4 | 1.25e-2 ✓ sig. |
| adherens junction disassembly | GO:0120179 | 1 / 1 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| rhombomere 6 development | GO:0021572 | 1 / 1 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| negative regulation of cortisol secretion | GO:0051463 | 1 / 1 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| negative regulation of growth hormone secretion | GO:0060125 | 1 / 1 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| intestinal epithelial cell migration | GO:0061582 | 1 / 1 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| female somatic sex determination | GO:0019101 | 1 / 1 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| granulosa cell differentiation | GO:0060014 | 1 / 1 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| rhombomere 5 development | GO:0021571 | 1 / 2 | 623× | 1.60e-3 | 1.98e-2 ✓ sig. |
| abducens nerve formation | GO:0021599 | 1 / 2 | 623× | 1.60e-3 | 1.98e-2 ✓ sig. |
| microvillus organization | GO:0032528 | 1 / 2 | 623× | 1.60e-3 | 1.98e-2 ✓ sig. |
| brain segmentation | GO:0035284 | 1 / 3 | 415× | 2.41e-3 | 2.50e-2 ✓ sig. |
| response to platelet-derived growth factor | GO:0036119 | 1 / 3 | 415× | 2.41e-3 | 2.50e-2 ✓ sig. |